Agrima Mian (@agrimamianmd) 's Twitter Profile
Agrima Mian

@agrimamianmd

Heme/Onc fellow @ClevelandClinic @ccfhemonc @ASH_hematology Trainee Council via @CCF_IMCHIEFS @aiims_newdelhi, @kmc_manipal 🇮🇳🇺🇸

ID: 1106733698072961026

linkhttps://scholar.google.com/citations?user=iCJrquMA calendar_today16-03-2019 01:47:30

1,1K Tweet

1,1K Followers

1,1K Following

Smitha Krishnamurthi (@smitha42) 's Twitter Profile Photo

It’s #ColorectalCancerAwareness month! A great time to highlight National Cancer Institute National Cancer Institute sponsored #CancerClinicalTrial CIRCULATE-NORTH AMERICA. This trial led by Dr. Chris Lieu and Arvind Dasari, MD, MS is for patients with stage III or high risk stage II colon cancer and will

It’s #ColorectalCancerAwareness month! A great time to highlight National Cancer Institute <a href="/theNCI/">National Cancer Institute</a> sponsored #CancerClinicalTrial CIRCULATE-NORTH AMERICA. This trial led by Dr. Chris Lieu and <a href="/adasarimd/">Arvind Dasari, MD, MS</a> is for patients with stage III or high risk stage II colon cancer and will
Ajay Major, MD, MBA (@majorajay) 's Twitter Profile Photo

RW lonca R/R DLBCL outcomes: - 187 pts, 17% bulky, 22% HGBL, 60% prior CAR - ORR 32%, CR 14% (woof), no diff in outcomes if prior CAR - mEFS 2.1 mos, mOS 4.6 mos Dismal outcomes outside of trial setting. #lymsm pubmed.ncbi.nlm.nih.gov/39540227/

RW lonca R/R DLBCL outcomes:
- 187 pts, 17% bulky, 22% HGBL, 60% prior CAR
- ORR 32%, CR 14% (woof), no diff in outcomes if prior CAR
- mEFS 2.1 mos, mOS 4.6 mos
Dismal outcomes outside of trial setting. #lymsm
pubmed.ncbi.nlm.nih.gov/39540227/
Sanam Loghavi, MD صنم لغوی 🔬🧬 (@sanamloghavi) 's Twitter Profile Photo

Did you know that the parent clone for MGUS is ~16 yr old, SMM is ~21 yr old, & multiple myeloma is ~33 yr old on average by the time the pt gets diagnosed??? 🤯 Fascinating data from Jean-Baptiste Alberge and Irene Ghobrial lab at #IBC2025 VJHemOnc

Did you know that the parent clone for MGUS is ~16 yr old, SMM is ~21 yr old, &amp; multiple myeloma  is ~33 yr old on average by the time the pt gets diagnosed??? 🤯
Fascinating data from Jean-Baptiste Alberge and <a href="/IrenemGhobrial/">Irene Ghobrial</a>  lab at #IBC2025 <a href="/VJHemOnc/">VJHemOnc</a>
The Lancet Haematology (@thelancethaem) 's Twitter Profile Photo

📢CAR T-cells for relapsed/refractory B-cell malignancies in India: phase 1/2 trial 📈Safety: no ICANS, low incidence of severe CRS, manageable haematological toxicities, 2 treatment-related deaths. 🔍Activity: 73% overall response rate.Rahul Purwar 👇 shorturl.at/x11Ip

Meera Mohan (@meeramohanmd) 's Twitter Profile Photo

Congratulations to Rahul Banerjee, MD, FACP Gurbakhash Kaur on this important work We follow the 4-week driving restrictions for our patients post CAR T, it's good to have data that supports what we already do clinically MCW Cancer Center #mmsm

Hira Mian (@hirasmian) 's Twitter Profile Photo

i had missed reading this study nature.com/articles/s4140…, curious for patients > 12-24 months relpase post BCMA CART, are you target switching? Tec or Talq? and if you go with talq, do you then come back with tec? Ben Derman Rahul Banerjee, MD, FACP Samer Al Hadidi, MD,MS,FACP Raj Chakraborty

Andrew M. Evens, DO, MBA, MSc (@draevens) 's Twitter Profile Photo

🚨🚨🚨 It is GREAT to be back in the Windy City for our 22nd International Ultmann #Chicago #Lymphoma Symposium (#IUCLS2025). Excited for multiple great talks & back again for the WALK-UP songs! 🥁🎤🎵 Follow here for highlights! bioascend.com/chicago-lympho… Soni Smith MD Tim Fenske

🚨🚨🚨 It is GREAT to be back in the Windy City for our 22nd International Ultmann #Chicago #Lymphoma Symposium (#IUCLS2025).

Excited for multiple great talks &amp; back again for the WALK-UP songs! 🥁🎤🎵

Follow here for highlights! bioascend.com/chicago-lympho…

<a href="/SoniSmithMD/">Soni Smith MD</a> <a href="/timfenske/">Tim Fenske</a>
Blood Advances (@bloodadvances) 's Twitter Profile Photo

Ferritin is the best test for predicting bone marrow iron stores in patients with hematologic disorders. Other blood tests do not add value. ow.ly/kRmZ50VxvZQ #redcellsironanderythropoiesis

Ferritin is the best test for predicting bone marrow iron stores in patients with hematologic disorders. Other blood tests do not add value. ow.ly/kRmZ50VxvZQ #redcellsironanderythropoiesis
Vincent Rajkumar (@vincentrk) 's Twitter Profile Photo

Solitary plasmacytoma: Mayo Clinic experience and systematic review and meta-analysis of clinical outcomes ⁦Blood Advances⁩ ⁦Mayo Clinic Comprehensive Cancer Center⁩ #OpenAccess ashpublications.org/bloodadvances/…

Jame Abraham, MD, FACP (@jamecancerdoc) 's Twitter Profile Photo

We are excited to announce the Inaugural Cleveland Clinic Artificial Intelligence Healthcare summit in July - in partnership with CHIME Keynote speaker David Rhew of Microsoft clevelandclinicmeded.com/live/courses/a… Speakers including Anant Madabhushi Dr Anthony Chang Andrea Sikora

We are excited to announce the Inaugural <a href="/ClevelandClinic/">Cleveland Clinic</a> Artificial Intelligence Healthcare summit in July - in partnership with <a href="/CIOCHIME/">CHIME</a> Keynote speaker <a href="/drhew/">David Rhew</a> of <a href="/Microsoft/">Microsoft</a>  clevelandclinicmeded.com/live/courses/a… Speakers including <a href="/anantm/">Anant Madabhushi</a> <a href="/AnthonyChangMD/">Dr Anthony Chang</a> <a href="/AndreaSikora/">Andrea Sikora</a> …
Ajay Major, MD, MBA (@majorajay) 's Twitter Profile Photo

We are seeking patients with relapsed or refractory FL or DLBCL for a compensated study about experiences with bispecific antibody therapies. To my #lymsm & #onctwitter colleagues: please share the attached flyer with your networks. Thank you! #tcellrx

We are seeking patients with relapsed or refractory FL or DLBCL for a compensated study about experiences with bispecific antibody therapies. To my #lymsm &amp; #onctwitter colleagues: please share the attached flyer with your networks. Thank you! #tcellrx